Covaxin Recommended For Next Phase Of Trials For 2-18 Age Group: Report
Bharat Biotech's COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase-2 and phase-3 clinical trials on those aged between two to 18 years, official sources said.
No comments:
Post a Comment